Trials / Completed
CompletedNCT05088499
The Role of Genetic Factors in the Development of Epilepsy in the Kazakh Population
Preventive and Personalized Medicine (2021-2023)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- Asfendiyarov Kazakh National Medical University · Academic / Other
- Sex
- All
- Age
- 0 Years – 5 Years
- Healthy volunteers
- —
Summary
This is a GWAS study that aims to identify possible candidate genes associate to epilepsy by exploring single nucleotide polymorphism (SNP) in a group of epilepsy, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with epilepsy
Detailed description
A genome-wide association study (GWAS) is an approach used in genetics research to associate specific genetic variations with particular diseases. The method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease. Once such genetic markers are identified, they can be used to understand how genes contribute to the disease and develop better prevention and treatment strategies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | DNA analysis | GWAS |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2023-01-20
- Completion
- 2023-01-20
- First posted
- 2021-10-22
- Last updated
- 2023-03-14
Locations
1 site across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT05088499. Inclusion in this directory is not an endorsement.